Skip to main content
ADMA
NASDAQ Life Sciences

ADMA Biologics Launches $125M Accelerated Share Repurchase, Part of ~$200M 2026 Buyback Plan

Tom Rudovsky · Reported by Unknown
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$15.97
Mkt Cap
$3.708B
52W Low
$13.5
52W High
$25.67
52W Position info
18% above low
Off High info
38% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

ADMA sits 18% above its 52-week low of $13.5 on elevated volume (1.8× avg).

Summary

ADMA Biologics has announced a significant capital return initiative, launching a $125 million accelerated share repurchase (ASR) program with JPMorgan. This ASR is part of a broader plan to repurchase approximately $200 million of common stock throughout 2026, funded via borrowings under its $225M revolving credit facility. The company will initially receive about 6.4 million shares. This move follows the company's recent report of record full-year 2025 financial results, including strong revenue and Adjusted EBITDA growth, indicating a robust financial position. The substantial share repurchase program signals management's confidence in the company's valuation and commitment to enhancing shareholder value, making it a material event for investors.

At the time of this announcement, ADMA was trading at $15.97 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.7B. The 52-week trading range was $13.50 to $25.67. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Unknown.


Price Chart

Share this article

Copied!

ADMA - Latest Insights

ADMA
Nov 04, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $14.00
Real-time Price: $13.27 info
Change: -$0.7323 (-5%) info
Market Cap: $2.959B info
ADMA
Nov 04, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $11.14
Real-time Price: $13.27 info
Change: +$2.13 (+19%) info
Market Cap: $2.959B info
ADMA
Aug 10, 2026, 7:37 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $9.98
Real-time Price: $13.27 info
Change: +$3.29 (+33%) info
Market Cap: $2.959B info
ADMA
Aug 05, 2026, 5:16 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $9.11
Real-time Price: $13.27 info
Change: +$4.16 (+46%) info
Market Cap: $2.959B info
ADMA
Jul 16, 2026, 10:09 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $8.88
Real-time Price: $13.27 info
Change: +$4.39 (+49%) info
Market Cap: $2.959B info